Showing results (291-300 of 415) with videos related to
Sort By:
Pageof 42
Cancer Research|November 1, 1981
Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphomaT W LeBien, R W McKenna, C S Abramson, et al.Leukemia & Lymphoma|June 6, 2013
Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory diseaseJacob D Soumerai, Matthew D Hellmann, Yang Feng, et al.Histopathology|May 5, 2016
Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western populationPenelope A McKelvie, Fina Climent, Gregor Krings, et al.AIDS (London, England)|March 20, 2010
Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in ChinaLucette A Cysique, Scott L Letendre, Christopher Ake, et al.Theranostics|July 23, 2016
Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field ApplicationsDivya Pathania, Hyungsoon Im, Aoife Kilcoyne, et al.The Journal of Pediatrics|July 1, 1986
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trialW A Marks, H R Stutman, M I Marks, et al.Health Education Quarterly|January 1, 1989
A family approach to cardiovascular risk reduction: results from the San Diego Family Health ProjectP R Nader, J F Sallis, T L Patterson, et al.Journal of Global Oncology|September 23, 2018
Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From BotswanaMichael G Milligan, Elizabeth Bigger, Jeremy S Abramson, et al.The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.Abdominal Radiology (New York)|June 18, 2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patientsWendy Atkinson, Ciprian Catana, Jeremy S Abramson, et al.Pageof 42